Inversago Pharma
Inversago Pharma is a Canadian biotech company at clinical-stage, specializing in the development of new therapies focusing on CB1 blockade.
3
Funding Rounds
$110.7m
Money raised
Overview
Inversago Pharma is a Canadian biotech company at clinical-stage, specializing in the development of new therapies focusing on CB1 blockade.
- Website:
- Business model: B2B
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Inversago Pharma has raised a total of $110.74m in funding over 3 rounds.
Key Insights:
- Inversago Pharma - Series C round, October 2022: $68.74m
- Inversago Series B round, September 2020: $35m
- Inversago Pharma Series A round, July 2018: $7m
Inversago Pharma - Series C round, October 2022
$68.74m
Inversago Series B round, September 2020
$35m
Inversago Pharma Series A round, July 2018
$7m
Industries
Inversago Pharma is active in the following industries: